We do the sorting. You do the medicine.
Medical and endocrine disease16 / 30

Carcinoid syndrome for liver ablation in radiology56-year-old woman, 68 kg, for radiofrequency ablation of liver metastases under general anaesthesia in interventional radiology

From memory: the diagnosis and the notes are hidden. Answer each question aloud, then press Show.

Know this first

  • The syndrome needs liver metastases: the liver normally inactivates the tumour's peptides.
  • The right heart and valves are hit; the lungs clear the mediators, sparing the left.
  • Prophylaxis: octreotide 500 mcg IV, then 500 mcg/h; crisis bolus 50–300 mcg IV.
  • Catecholamines and histamine-releasing drugs can provoke mediator release.

The patient

56-year-old woman, 68 kg, for radiofrequency ablation of liver metastases under general anaesthesia in interventional radiology. Metastatic midgut neuroendocrine tumour with daily flushing and diarrhoea; echo shows tricuspid regurgitation. Drugs: monthly lanreotide depot. Vitals: BP 112/70, HR 88, SpO2 97% on air, RR 14. K+ 3.2 mmol/L.

The examiner asks

Answer aloud, then press Show.

  1. Consider

    What are your concerns?

    Show the answerHide the answer
    • A 56-year-old with metastatic midgut neuroendocrine tumour and active carcinoid syndrome, for elective liver ablation in radiology. Patient
    • Her liver deposits release serotonin into the systemic veins, so hepatic clearance is bypassed. Disease
    • Her tricuspid regurgitation is carcinoid heart disease; the lungs protect her left-sided valves.
    • Diarrhoea has dropped her potassium to 3.2; I correct it and check her fluid status.
    • Ablating tumour can set off a crisis; crises are reported during and soon after ablation. Surgery
    • Radiology is a remote site; her equipment must match theatre standards.
  2. Prepare

    How will you prepare her?

    Show the answerHide the answer
    • Her echo's right ventricular function and TR grade reviewed; repeat if it is old. Disease
    • Urinary 5-HIAA to judge how well lanreotide is controlling her syndrome.
    • Lanreotide continues; octreotide 500 mcg IV before the start, then 500 mcg/h.
    • Extra octreotide drawn up for boluses, with vasopressin and phenylephrine on the cart. Crisis
    • In radiology I check a full anaesthetic machine, monitors, capnography, suction and a trained assistant. Surgery
    • Benzodiazepine premedication, because fear and stress can trigger her mediator release. Stem trigger
  3. Plan

    How will you anaesthetise her?

    Show the answerHide the answer
    • Arterial line before induction; her pressure can swing either way within seconds. Disease
    • Propofol, fentanyl and rocuronium; no atracurium or morphine, which release histamine.
    • Adrenaline, noradrenaline and ephedrine are not my first-line pressors; catecholamines can trigger release. Stem trigger
    • Deep anaesthesia before laryngoscopy and before the probe heats, to block her sympathetic surge.
    • Measured fluids only; her right heart may already be failing. Disease
    • Ondansetron for nausea, and glucose checks, because octreotide often raises her sugar. After surgery
  4. Crisis

    As the ablation starts, BP is 210/115, HR 130, and her face and chest flush. What do you do?

    Show the answerHide the answer
    • This is a carcinoid crisis set off by the ablation; I ask radiology to stop heating. (Crisis)
    • Octreotide 50–300 mcg IV now, repeated until the surge settles.
    • Deepen her anaesthetic, since the stimulus may have outrun it.
    • If still high, a short-acting antihypertensive, titrated; I had it ready.
    • I check airway pressure; bronchospasm here gets octreotide, not salbutamol or adrenaline.
  5. Crisis

    In recovery she is flushed, BP 74/40, HR 112, SpO2 95%. What now?

    Show the answerHide the answer
    • A second crisis, now with hypotension; mediators keep coming after ablation. Crisis
    • Octreotide bolus again, with a small fluid bolus while I watch her right heart.
    • If she stays low, vasopressin or phenylephrine, not a catecholamine.
    • Her metastases still secrete, so octreotide continues after the procedure. After surgery
    • She goes to HDU or ICU, watched for further crises.

Fatal mistakes

  • Treating carcinoid hypotension with adrenaline or noradrenaline.
  • Starting the ablation with no octreotide drawn up.
  • Large fluid boluses into a right heart damaged by carcinoid valve disease.

Checked against: Miller 10e · Stoelting 8e · Faust · NANETS consensus guidelines for small bowel neuroendocrine tumors (2017) · Barash 9e

Report a problem with this case

Mark Got it only if you said every point. Again brings the case back tomorrow; Got it brings it back in 3, then 7, 14 and 30 days.

All Medical and endocrine disease casesBack to today